Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Lassailly

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2022
Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver TransplantationKate Minoux, Guillaume Lassailly, Massih Ningarhari, et al.
Plos One|March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataThierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
Cardiovascular and Interventional Radiology|October 25, 2014
Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation StudyXavier Pauwels, Mustapha Azahaf, Guillaume Lassailly, et al.
The American Journal of Gastroenterology|July 15, 2015
Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complicationJérôme Dumortier, Sébastien Dharancy, Amélie Cannesson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 30, 2020
Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patientsClementine Levy, Guillaume Lassailly, Mehdi El Amrani, et al.
Gut|March 4, 2015
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitisLaurent Dubuquoy, Alexandre Louvet, Guillaume Lassailly, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 29, 2019
Natural History of Recurrent Alcohol-Related Cirrhosis After Liver Transplantation: Fast and FuriousDomitille Erard-Poinsot, Sébastien Dharancy, Marie-Noëlle Hilleret, et al.
European Journal of Gastroenterology & Hepatology|April 19, 2011
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesityGuillaume Lassailly, Robert Caiazzo, Antoine Hollebecque, et al.
Journal of Hepatology|January 28, 2019
Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion moleculesGuillaume Lassailly, Mohamed Bou Saleh, Natascha Leleu-Chavain, et al.
Metabolism: Clinical and Experimental|January 14, 2024
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgeryVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Transplant International : Official Journal of the European Society for Organ Transplantation|November 28, 2022
Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver TransplantationKate Minoux, Guillaume Lassailly, Massih Ningarhari, et al.
Plos One|March 21, 2012
Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataThierry Poynard, Guillaume Lassailly, Emmanuel Diaz, et al.
Cardiovascular and Interventional Radiology|October 25, 2014
Drug-Eluting Beads Loaded With Doxorubicin (DEBDOX) Chemoembolisation Before Liver Transplantation for Hepatocellular Carcinoma: An Imaging/Histologic Correlation StudyXavier Pauwels, Mustapha Azahaf, Guillaume Lassailly, et al.
The American Journal of Gastroenterology|July 15, 2015
Recurrent alcoholic cirrhosis in severe alcoholic relapse after liver transplantation: a frequent and serious complicationJérôme Dumortier, Sébastien Dharancy, Amélie Cannesson, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 30, 2020
Transcatheter aortic valve replacement (TAVR) as bridge therapy restoring eligibility for liver transplantation in cirrhotic patientsClementine Levy, Guillaume Lassailly, Mehdi El Amrani, et al.
Gut|March 4, 2015
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitisLaurent Dubuquoy, Alexandre Louvet, Guillaume Lassailly, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 29, 2019
Natural History of Recurrent Alcohol-Related Cirrhosis After Liver Transplantation: Fast and FuriousDomitille Erard-Poinsot, Sébastien Dharancy, Marie-Noëlle Hilleret, et al.
European Journal of Gastroenterology & Hepatology|April 19, 2011
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesityGuillaume Lassailly, Robert Caiazzo, Antoine Hollebecque, et al.
Journal of Hepatology|January 28, 2019
Nucleotide-binding oligomerization domain 1 (NOD1) modulates liver ischemia reperfusion through the expression adhesion moleculesGuillaume Lassailly, Mohamed Bou Saleh, Natascha Leleu-Chavain, et al.
Metabolism: Clinical and Experimental|January 14, 2024
Performance of non-invasive tests for liver fibrosis resolution after bariatric surgeryVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Pageof 7